Загрузка...
Modifications of medical treatment and outcome after percutaneous correction of secondary mitral regurgitation
AIMS: The optimization of guideline‐directed medical therapy (GDMT) in reduced ejection fraction heart failure (HFrEF) is associated with improved survival and can reduce the severity of secondary mitral regurgitation (SMR). Highest tolerated doses should be achieved before percutaneous mitral valve...
Сохранить в:
Опубликовано в: : | ESC Heart Fail |
---|---|
Главные авторы: | , , , , , , , , , , , , , , , |
Формат: | Artigo |
Язык: | Inglês |
Опубликовано: |
John Wiley and Sons Inc.
2020
|
Предметы: | |
Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7373897/ https://ncbi.nlm.nih.gov/pubmed/32426906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12737 |
Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|